ASLAN Pharma Stock (NASDAQ: ASLN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.234M |
Day Range | - - - |
52 Wk Range | 0.392 - 4.690 |
Market Cap | $9.062M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.12% |
Days to Cover | 1.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ASLAN Pharma (NASDAQ: ASLN) through any online brokerage.
Other companies in ASLAN Pharma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Addex Therapeutics (NASDAQ:ADXN), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
The latest price target for ASLAN Pharma (NASDAQ: ASLN) was reported by HC Wainwright & Co. on Friday, May 3, 2024. The analyst firm set a price target for 9.00 expecting ASLN to rise to within 12 months (a possible 2147.19% upside). 13 analyst firms have reported ratings in the last year.
The stock price for ASLAN Pharma (NASDAQ: ASLN) is $0.4005 last updated May 13, 2024 at 6:46 PM EDT.
There are no upcoming dividends for ASLAN Pharma.
ASLAN Pharma’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for ASLAN Pharma.
ASLAN Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.